Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why ...

MSD – known as Merck & Co in North America – acquired rights to PRA023 (now MK-7240) when it bought Prometheus Biosciences for $10.8 billion earlier this year, while Roche was recently ...

MSD, known as Merck & Co in the US and Canada ... notably buying Acceleron for $11.5 billion in 2021 and Prometheus for $10.8 billion a year later, along with several smaller-scale deals.

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best large-cap value stocks to buy as the recession hits. Goldman Sachs highlighted that ...

In this article, we are going to take a look at where Merck & Co. Inc. (NYSE:MRK) stands against other high growth forever dividend stocks. Dividend stocks have trailed the broader market over the ...

Lusaka [Zambia] / Mumbai (Maharashtra) [India], April 16: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks 'World Art Day 2025' through their Pan African 'Art and Fashion with ...

Merck MRK is a healthcare company that manufactures pharmaceutical products to treat various conditions in many therapeutic areas, including cardiometabolic disease, cancer and infections ...

In this article, we are going to take a look at where Merck & Co Inc. (NYSE:MRK) stands against other undervalued quality stocks to buy now. On February 24, Kayne Anderson Rudnick chief market ...